Clinical Trials Logo

Filter by:
NCT ID: NCT04592510 Recruiting - SARS-CoV2 Clinical Trials

Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave.

Start date: May 25, 2021
Phase:
Study type: Observational

Assessment of impact of covid-19 on pediatric dental practice during first, second and third wave among a group of pediatric dentists.

NCT ID: NCT04590534 Recruiting - Clinical trials for Prostatic Hyperplasia

Evaluation of the Effect of Garcinia in Combination With Chromium on the Clinical Outcomes of Patients With LUTS/BPH

BPH
Start date: August 1, 2020
Phase: Phase 2
Study type: Interventional

To evaluate efficacy and safety of garcinia extract + chromium combinations (Chromax) in symptomatic benign prostatic hypertrophy patients

NCT ID: NCT04590157 Recruiting - Clinical trials for Stress Urinary Incontinence

Neuromodulation Effect of Laser Acupuncture on Stress Urinary Incontinence

Start date: October 15, 2020
Phase: N/A
Study type: Interventional

background:Stress urinary incontinence (SUI) is the most common type of urinary incontinence in women, as it involves involuntary leakage of urine , the current study was To determine the neuromodulation effect of Laser Therapy on Neurogenic Acupoints in female with stress urinary incontinence (SUI).

NCT ID: NCT04589494 Recruiting - Chronic Pain Clinical Trials

Effect of Tramadol Versus Morphine on PD1 and PD1-ligand in Patients With Chronic Cancer Pain

Start date: April 16, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

this work is looking for comparison between the effect of tramadol versus morphine on PD1 and PD1-ligand in patients with chronic cancer pain

NCT ID: NCT04589429 Recruiting - Pain, Postoperative Clinical Trials

Adding Nalbuphine for Control of Intrathecal Morphine Pruritus

Start date: October 15, 2020
Phase: Phase 2
Study type: Interventional

Intrathecal morphine causes intense itching which is very bothersome. Nalbuphine antagonizes this effect when given intravenously. This trial is to find out if nalbuphine added to intrathecal morphine has an effect on morphine related pruritus while still maintaining adequate analgesia.

NCT ID: NCT04586790 Recruiting - Spinal Shock Clinical Trials

the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock

Start date: October 15, 2020
Phase: Phase 2
Study type: Interventional

the study is developed to evaluate the effect of use of oral vasopressors (midodrine versus minirin) on weaning ICU patients from IV vasopressors (noradrenaline) and compare between them for efficacy in shortage the duration of IV vasopressor and has low complications and side effects.

NCT ID: NCT04584905 Recruiting - Clinical trials for Nutrition Disorders, Child

Nutritional Assessment of Children With Chronic Kidney Disease

Start date: January 1, 2021
Phase:
Study type: Observational

Primary outcome is assessment of nutritional status of children with CKD. Secondary outcome is assessment STAMP screening tool for detection of malnutrition of CKD children.

NCT ID: NCT04584606 Recruiting - Clinical trials for Coronavirus Disease (COVID-19)

Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients

Start date: June 27, 2020
Phase:
Study type: Observational

COVID-19 as a novel disease, different disease patterns were observed worldwide, and many treatment plans were tried. So, it is important to investigate the Egyptian clinical characteristics and different factors that determine the patient's 'outcome

NCT ID: NCT04584580 Recruiting - Clinical trials for Coronavirus Disease (COVID)19

D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia

Start date: August 1, 2020
Phase: Phase 4
Study type: Interventional

evaluation of the efficacy and safety of D-dimer adjusted heparin versus therapeutic dose heparin in patients with COVID-19 Pneumonia.

NCT ID: NCT04583566 Recruiting - Clinical trials for Corona Virus Infection

Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's Patients

Start date: October 4, 2020
Phase:
Study type: Observational [Patient Registry]

The aim of this effort is to study host-pathogen interaction in Egyptian patients infected with COVID-19. The investigators will perform genome-wide miRNA and transcriptome screens in the infected patients along with healthy ones for comparison. All types of cytokines play pivotal roles in immunity, including the responses to different viral infections. Therefore, The investigators will study the cytokines profile in response to that infection. By comparing miRNA and transcriptome screens along with cytokines profiles, an important molecule might be identified that could play role in the inhibition of the COVID-19 outbreak. In addition, this information will help us gaining awareness of the immune process and knowing about the genes involved in the immune response against COVID-19 with an emphasis on the expression of cytokines.